Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.260
+0.110 (3.49%)
At close: Aug 11, 2026, 4:00 PM EDT
3.251
-0.009 (-0.29%)
After-hours: Aug 11, 2026, 7:52 PM EDT
Prime Medicine Revenue
Prime Medicine had revenue of $1.15M in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's revenue in the last twelve months to $4.07M, down -17.90% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth.
Revenue (ttm)
$4.07M
Revenue Growth
-17.90%
P/S Ratio
142.39
Revenue / Employee
$27,897
Employees
146
Market Cap
579.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.63M | 1.65M | 55.28% |
| Dec 31, 2024 | 2.98M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 132.42M |
| Autolus Therapeutics | 92.62M |
| 4D Molecular Therapeutics | 88.24M |
| Adlai Nortye | 5.00M |
| Shattuck Labs | 1.00M |
| Silence Therapeutics | 839.00K |
| Artiva Biotherapeutics | 251.00K |
PRME News
- 5 days ago - Prime Medicine reports Q4 EPS (24c), consensus (26c) - TheFly
- 5 days ago - Prime Medicine Quarterly report: Q2 2026 - Filings
- 5 days ago - Prime Medicine Earnings release: Q2 2026 - Filings
- 19 days ago - Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease - GlobeNewsWire
- 4 weeks ago - TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647 - TheFly
- 4 weeks ago - Resolution in favor of Prime has limited impact to Beam, says BofA - TheFly
- 4 weeks ago - Prime Medicine reports positive resolution to arbitration with Beam Therapeutics - TheFly
- 4 weeks ago - Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics - GlobeNewsWire